Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Operating Margin: 2015-2020

Historic Operating Margin for Outlook Therapeutics (OTLK) over the last 6 years, with Sep 2020 value amounting to 52,617.92%.

  • Outlook Therapeutics' Operating Margin rose 5283474.00% to 52,617.92% in Q3 2020 from the same period last year, while for Sep 2020 it was 2,097.42%, marking a year-over-year increase of 254302.00%. This contributed to the annual value of 2,271.27% for FY2024, which is 17243.00% up from last year.
  • Outlook Therapeutics' Operating Margin amounted to 52,617.92% in Q3 2020, which was up 1,865.00% from 2,677.76% recorded in Q2 2020.
  • In the past 5 years, Outlook Therapeutics' Operating Margin ranged from a high of 52,617.92% in Q3 2020 and a low of -5,870.30% during Q4 2016.
  • In the last 3 years, Outlook Therapeutics' Operating Margin had a median value of -884.97% in 2018 and averaged 4,623.81%.
  • Per our database at Business Quant, Outlook Therapeutics' Operating Margin slumped by 422,056bps in 2016 and then spiked by 5,283,474bps in 2020.
  • Over the past 5 years, Outlook Therapeutics' Operating Margin (Quarterly) stood at -5,870.30% in 2016, then soared by 545,836bps to -411.95% in 2017, then tumbled by 54,884bps to -960.78% in 2018, then soared by 233,012bps to 1,369.33% in 2019, then spiked by 5,283,474bps to 52,617.92% in 2020.
  • Its Operating Margin stands at 52,617.92% for Q3 2020, versus 2,677.76% for Q2 2020 and 971.59% for Q1 2020.